US equities
|
SPCX
$166.88
▲+4.99%
NVDA
$236.79
▲+1.22%
MU
$1,064.42
▼-0.97%
TSLA
$377.27
▲+1.80%
MSFT
$525.09
▲+1.46%
SNDK
$1,707.59
▼-0.72%
INTC
$117.38
▼-1.64%
META
$742.96
▲+2.04%
SPCX
$166.88
▲+4.99%
NVDA
$236.79
▲+1.22%
MU
$1,064.42
▼-0.97%
TSLA
$377.27
▲+1.80%
MSFT
$525.09
▲+1.46%
SNDK
$1,707.59
▼-0.72%
INTC
$117.38
▼-1.64%
META
$742.96
▲+2.04%
FinancialContent
Sign in
Markets
Overview
News
World markets
Treasuries
Currencies
Commodities
Economy
Stocks
Overview
Most active
Gainers
Losers
Largest companies
52-week gainers
52-week losers
ETFs
Overview
Popular funds
Most active
Gainers
Losers
News
Research
Search
Sectors
Articles published by Covant Therapeutics
Covant Therapeutics Appoints Vincent Hennemand as Chief Executive Officer
October 13, 2023
From
Covant Therapeutics
Via
GlobeNewswire
Tickers
ROIV
Covant and Boehringer Ingelheim Collaborate to Develop a Novel ADAR1 Inhibitor for Use in Cancer Patients
March 28, 2023
From
Covant Therapeutics
Via
GlobeNewswire
Tickers
ROIV